Buy & Sell Moderna, Inc. (MRNA) – Moderna, Inc. Price Today
Key Stats
- $19.47BMarket Cap
- HealthSector
- -18.94%3M Drawdown
- $15.56BEnterprise Value
- -Dividend Yield
- 4% Buy | 96% SellTrading Activity
- 70 daysTypical Hold Time
Moderna, Inc. (MRNA) is currently valued at a market capitalization of $19.47B, with an enterprise value of $15.56B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -18.94%, reflecting recent price volatility. On average, investors hold Moderna, Inc. for approximately 70 days, indicating typical investor behavior on the platform.
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Most Recent News
MGP Ingredients rated a long-term buy despite U.S. whiskey market challenges and sales declines.
MGP Ingredients, a key player in the U.S. whiskey market, faces near-term operational challenges due to an oversupply of American whiskey, leading to distillery closures and significant sales declines. Despite these headwinds, the company maintains a...

Tianjin Shipping Expo spotlights AI's growing role in transforming global shipping and port operations.
The 4th Tianjin International Shipping Industry Expo highlighted the expanding use of AI in the shipping sector, focusing on innovations like automated container terminals and intelligent logistics. Industry leaders emphasized AI's potential to enhan...

Fangzhou unveils AI-driven chronic disease management solution with Tencent Health at Tencent Cloud Summit
Fangzhou Inc. showcased its AI-powered chronic disease management solution developed with Tencent Health at the 2026 Tencent Cloud AI Industry Applications Summit. The solution integrates AI to support patients with personalized care and physicians w...
